首页> Breast cancer (Dove Medical Press)> Aromatase inhibitor-associated bone loss and its management with bisphosphonates in patients with breast cancer.

Aromatase inhibitor-associated bone loss and its management with bisphosphonates in patients with breast cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： M,Bauer

第一单位： University of Marburg, Marburg, Germany.

作者： M,Bauer ^[1] ; J,Bryce ^[2] ; P,Hadji ^[1]

作者单位： University of Marburg, Marburg, Germany. ^[1] National Cancer Institute, Naples, Italy. ^[2]

关键词 aromatase inhibitors bisphosphonates bone loss breast cancer estrogen

DOI 10.2147/BCTT.S29432

PMID 24367197

发布时间 2024-06-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览72

Breast cancer (Dove Medical Press)

2012年4卷

91-101页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览72

点击下载本期目录封面

Breast cancer (Dove Medical Press)

2012年4卷

91-101页

检索历史清除

Aromatase inhibitor-associated bone loss and its management with bisphosphonates in patients with breast cancer.

Breast cancer (Dove Medical Press)

相似文献

同项目论文

Breast cancer (Dove Medical Press)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Aromatase inhibitor-associated bone loss and its management with bisphosphonates in patients with breast cancer.

Breast cancer (Dove Medical Press)

相似文献

同项目论文

Breast cancer (Dove Medical Press)

相关期刊

检索历史清除